For patients with metabolic dysfunction-associated steatotic liver disease (MASLD), the association between liver fibrosis and atherosclerotic cardiovascular disease (ASCVD) varies with glycemic status, according to a study published in Hepatology Communications.
source https://medicalxpress.com/news/2026-07-link-liver-fibrosis-masld-ascvd.html
source https://medicalxpress.com/news/2026-07-link-liver-fibrosis-masld-ascvd.html
Comments
Post a Comment